Skip to main content

TCG — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

153
Companies
$1.8B
Total invested
$24.7M
Avg. check
43
Industries
Biotechnology 10Health Care 9Therapeutics 6Medical 5Pharmaceutical 3Biopharma 2+37 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 153
Pathalys Pharma
August 2024

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Biopharma · Raleigh$105.0M Series B
Curio
August 2024

Curio is bringing competitive gameplay to real money games, starting with Duper.

Gaming · San Francisco$5.7M Seed
Entrada Therapeutics
June 2024

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Biotechnology · Boston$100.0M Post-IPO Equity
Tourmaline Bio
January 2024

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

Biotechnology · New York$172.5M Post-IPO Equity
The Pro's Closet
January 2024

The Pro's Closet is a re-Commerce company that specializes in premium pre-owned bike and bike component sales.

Cycling · Boulder$20.1M Venture - Series Unknown
The Sill
January 2024

The Sill offers ceramic planters potted with houseplants.

Consumer Goods · New York$158K Equity Crowdfunding
Wthn
January 2024

Wthn is a natural wellness brand offering herbal medicine and acupuncture treatments.

Health Care · New York$5.0M Series A
Medallion
December 2023

Medallion develops a blockchain-based platform to connect artists and their fans.

Blockchain · New York$13.7M Series A
Alpine Immune Sciences
November 2023

Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.

Biotechnology · Seattle$150.0M Post-IPO Equity
Outdefine
October 2023

Outdefine -- The Learning and Execution Layer For Healthcare Systems.

Generative AI · San Francisco$2.8M Seed
Better Place Forests
August 2023

Better Place Forests provides memorial spreading forests for families who choose cremation.

Family · San Francisco$7.8M Venture - Series Unknown
Headspace
July 2023

Headspace is a mental health company offering AI companionship, coaching, therapy, psychiatry, and mindfulness tools for everyday support.

Artificial Intelligence (AI) · Santa Monica$105.0M Debt Financing
Upstream Bio
June 2023

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Biotechnology · Waltham$200.0M Series B
Alkeus Pharmaceuticals
June 2023

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Biotechnology · Cambridge$150.0M Series B
Cars & Bids
January 2023

Cars & Bids is an online auction marketplace to buy and sell modern enthusiast cars.

Automotive · San Diego$37.0M Series A
Synthekine
January 2023

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Biotechnology · Menlo Park$100.0M Series C
VectivBio
October 2022

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Biotechnology · Basel$125.0M Post-IPO Equity
Glass
September 2022

Glass is a video platform that enables creators to earn NFTs from their videos.

Content Creators · Los Angeles$5.0M Seed
Hume
September 2022

Hume provides a web3 record label creating music-driven metastars.

Information Technology · Los Angeles$11.7M Series A
Immortal Game
September 2022

Immortal Game Play-and-Earn. Free-to-Play. Immortal Game introduces a new layer of strategy to the most played board game in the world.

Blockchain · Paris$12.2M Series A
Allakos
September 2022

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Biopharma · Redwood City$150.0M Post-IPO Equity
RayzeBio
September 2022

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

Biotechnology · San Diego$160.0M Series D
Arkive
July 2022

Arkive is redefining culture by building the first-ever decentralized physical museum.

Internet · Santa Monica$9.7M Seed
Tribute Brand
July 2022

The world's first D2C digital fashion brand & tech house, producing 3D & AR/VR assets for apps, gaming and the metaverse.

E-Commerce · Zagreb$4.5M Seed

Where TCG invests

Biotechnology10
Health Care9
Therapeutics6
Medical5
Pharmaceutical3
Biopharma2

About TCG's portfolio

How many companies has TCG invested in?▸

TCG has invested in 153 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does TCG invest in?▸

TCG's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 43 different industry categories.

What is TCG's largest investment?▸

Among tracked funding rounds, Upstream Bio received $200.0M in a Series B round. TCG's total known invested capital is $1.8B.

What is the average investment size for TCG?▸

TCG's average investment size is $24.7M across its portfolio of 153 companies.

What are TCG's most recent investments?▸

Recent TCG portfolio additions include Pathalys Pharma, Curio, Entrada Therapeutics, Tourmaline Bio, The Pro's Closet. These companies were founded in 2020 or later.

Reach the founders behind these 153 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →